Role of Slowly Digesible Starch on Diabetes Risk Factors



Status:Completed
Conditions:Endocrine, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:35 - 65
Updated:12/17/2017
Start Date:August 2012
End Date:June 2016

Use our guide to learn which trials are right for you!

Role of Slowly Digesible Starch on Diabetes Risk Factors In Pre-diabetic People

The purpose of this study is to determine the effect of a slowly digesting starch on gut
bacteria, sugar and fat metabolism, hunger hormones, and body fat in people with
pre-diabetes.

In a double blind randomized controlled clinical trial, the investigators will test the
effect of slowly digesting starch (amylose) versus a placebo starch (amylopectin) on risk
factors for type 2 diabetes. For the study, about 95 obese participants (ages 35-65) with
pre-diabetes (impaired fasting glucose) will consume a yogurt containing about 45 g of either
the experimental or placebo starch daily for 3 months. The investigators will test the
hypothesis that, compared to controls, a daily intake of 45 g of amylose for 3 months will
improve risk factors for the development of type 2 diabetes (insulin sensitivity and
secretion) by decreasing ectopic fat depots and decreasing inflammation in parallel with a
change in colonic microbial populations.

Inclusion Criteria

- Have a body mass index between 30 and 44.9 kg/m2

- Are 35-65 years of age

- Have pre-diabetes, which means impaired fasting glucose (IFG)

- Are willing to complete nutritional and activity questionnaires and 2-3 weeks of
baseline testing

- Are willing to enroll in the 3-month intervention and maintain the same level of
exercise during the study

- Are willing to maintain weight throughout the study

Exclusion Criteria

- Have evidence of cardiovascular disease, diabetes, symptomatic cholelithiasis
(gallstones), or cancer

- Have a fasting blood glucose less than 100 mg/dL or greater than 125 mg/dL

- Have an average screening blood pressure > 150/100 mm Hg

- Are a pre-menopausal woman but do not have a regular menstrual cycle

- Are pregnant or breastfeeding

- Chronically use medications including diuretics, steroids, and adrenergic-stimulating
agents

- Have emotional problems such as clinical depression or other diagnosed psychological
conditions

- Use hormonal contraceptives, oral or parenteral glucocorticoids, or any other
medication known to influence glucose or insulin homeostasis (balance), within 1 month
of study

- Have a clinically significant gastrointestinal malabsorption syndrome, chronic
diarrhea, or use antibiotics within one month of study

- Have abnormal laboratory markers (e.g., elevated potassium levels, hemoglobin or
hematocrit below the lower limit of normal)

- Chronically consume alcohol (> 4 servings per day) or actively smoke cigarettes (> 1/4
pack per day)

- Are on any chronic medication that has not had a stable dose for 1 month or longer

- Are required to perform of any kind of heavy physical activity

- Have metal objects in the body, such as a pacemaker, metal pins, bullet, etc.
We found this trial at
1
site
6400 Perkins Rd
Baton Rouge, Louisiana 70808
(225) 763-2500
Principal Investigator: Eric Ravussin, PhD
Phone: 225-763-3000
Pennington Biomedical Research Center Unlike other medical research facilities where science occurs in separate labs...
634
mi
from
Baton Rouge, LA
Click here to add this to my saved trials